Biomimetic Inhalable Nanoparticle formulations for targeted pulmonary drug delivery applications

Funded partially by Rhode Island Foundation Medical Research

Exposure to micro- and nanoplastics by inhalation can lead to inflammation, lung damage, and can possibly also contribute to the risk of lung cancer. Menon’s lab would be interested in studying the effects of inhaled nanoplastics and plastic microfibers on cells in the lungs and developing ways to mitigate these effects through localized treatment using biocompatible and biodegradable formulations.

Additional Information:
Nanotherapeutics & Biomaterials Engineering Laboratory (Menon Lab)

URI Lead: Jyothi Menon

Bookmark the permalink.

Comments are closed.